Tight Glycemic Control: How Sweet It Is! Virginia Point of Care Coordinators April 22, 2005.

Slides:



Advertisements
Similar presentations
BLOOD GLUCOSE MONITORING Center For Diabetes Education at Tulsa Regional Medical Center.
Advertisements

PRESENTED BY RTN PP PHF RANJAN ALLES
Insulin Therapy in Type 2 Diabetes: Current and Future Directions
INSULIN THERAPY IN ICU Dr SANJAY KALRA, D.M. [AIIMS]
Managing Sick Days and Hospital Stays Mike Heile MD Orlando, CWD July, 2011.
Insulin Infusion Protocol in the ICU Changing Care…Changing Culture By: Holly Ann Roush, RN, BSN, Nurse Clinician level IV.
Perioperative Care Kimberly Ephgrave, MD, FACS Professor of Surgery University of Iowa Carver College of Medicine.
Presented By: Nancy Health Coach
Diabetes Self Management Laura Wintersteen-Arleth, MN, RN,CDE
Surgery In Diabetes Mellitus (DM)
Susan Alexander, DNP, CNS, CRNP, BC- ADM College of Nursing University of Alabama in Huntsville Clinical Affiliation: Outpatient Diabetes Self-Management.
Endocrinology and Metabolism in Intensive care 馬偕醫院內分泌暨新陳代謝科 陳偉哲.
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Spotlight Case May 2004 Too Tight Control: The Risks of Intensive Insulin Therapy.
DIABETES Cameron VanTassell MS,RD,BC-ADM. HbA1c Definition-a stable glycoprotein formed when glucose binds to hemoglobin A in the blood in a concentration.
Washington State Hospital Association Partnership for Patients Reducing Surgical Site Infections: Glucose Control Clinical Presentation July 10, 2012.
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
Canadian Diabetes Association Clinical Practice Guidelines In-Hospital Management of Diabetes Chapter 16 Robyn Houlden, Sara Capes, Maureen Clement, David.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Diabetes Claire Nowlan Nov 28, Comparison of type 1 and 2 diabetes Type 1 10% of diabetics Age of onset – young Severe Requires insulin Normal build.
Diabetes Mellitus.
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock Dellinger RP, Levy MM, Rhodes A, Annane D, Carcillo JA, Gerlach H,
Kate McHenry BSN, RN 3W Oncology Unit.  Overview of diabetes, cancer, and interactions between the two  Increased risk of certain cancers with the comorbid.
What is Diabetes?.
Diabetes Mellitus and the Surgical Patient Dr. Cathy Code Division of General Internal Medicine.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Homeostasis and Diabetes L2
Sugar control in Critical care unit Senior clinical pharmacist : Lihua Fang Koo Foundation Cancer Center.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
INTRODUCTION Stress-induced hyperglycaemia is common in critical care 1 Hyperglycaemia worsens patient outcomes, increasing risk of infection 2, myocardial.
Criteria for the diagnosis of DM Symptoms of diabetes plus random blood glucose concentration ≥ 200 mg/dl OR FPG ≥ 126 mg/dl OR Two –hour plasma glucose.
Homeostasis and Diabetes L3. What is Homeostasis? The maintenance of a constant internal environment, despite external changes is called Homeostasis.
The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
Session II: Glycemic control, when the lower is not the better Strict glycemic control and cardiovascular diseases Stefano Genovese Diabetologia e Malattie.

Optimizing Nutrition Therapy
Biosensors Data for Systems Analysis DuringConvalescence Palmer Q. Bessey, MD Burn Center Weill Medical College Biomedical Engineering Retreat Ithaca,
Nutrition and Metabolism Negative Feedback System Pancreas: Hormones in Balance Insulin & Glucagon Hormones that affect the level of sugar in the blood.
Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes ADA and AACE Guidelines: Room For Improvement.
Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
Postoperative Glucose Control and SCIP Measures Gorav Ailawadi, MD Chief, Adult Cardiac Surgery University of Virginia April 25, 2015.
Achieving Glycemic Control in the Hospital Setting Part 1 of 3
DIABETIC TEACHING VERMALYNPAULETTEMICHELLEEDWARD.
1 Challenges and Opportunities In Managing Diabetes and Hyperglycemia Module 2 Diabetes Special Interest Group Georgia Hospital Association.
Dixie L. Thompson chapter 20 Exercise and Diabetes.
Complex Medical Patients Wayne Katon, MD.  Definition: Illnesses with high prevalence, high comorbidity and bidirectional adverse interactions Examples:
Therapy for Type II Diabetes. Non-Insulin Therapy for Hyperglycemia in Type 2 Diabetes, Match Patient Characteristics to Drug Characteristics 5. Gut.
Medical Management of Diabetes During Ramadan Jennifer Hamilton, MD August, 2007 CE Rajab, 1428 AH.
Carina Signori, D.O., M.P.H. Penn State Hershey Medical Center Ceriello, Antonio. Diabetes Care August 2010;33,8.
Special Situations In The Management Of In-Patient Hyperglycemia
Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit Greet Hermans, Alexander.
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Safety and efficacy of insulin guideline for controlling perioperative hyperglycemia Marwa Amer PharmD Candidate1, Mark Shelly MD2, Dianne Lee PharmD Candidate1,
Care of Patients with Diabetes Mellitus
Perioperative Care Kimberly Ephgrave, MD, FACS Professor of Surgery
Diabetes and Stroke.
Chapter 26 Endocrine Function
Managing Hypoglycemia & Hyperglycemia
Perioperative Care Kimberly Ephgrave, MD, FACS Professor of Surgery
PowerPoint 16:9 Screen Ratio Template *
Presentation transcript:

Tight Glycemic Control: How Sweet It Is! Virginia Point of Care Coordinators April 22, 2005

Disclosures State faculty for the Surgical Infection Prevention Initiative No financial or other conflicts of interest –Claudette Dalton, M.D.

What, me worry? Surgical Infection Prevention Initiative (SIP) /Surgical Care Improvement Project (SCIP) Literature JCAHO/ CMS/ ACS/ ASA/ ICU/ POC/ NQF/ IOM/ QI/ PI/ VHQC ICU standard of care ? General standard of care

Core Knowledge Needed Impact on outcomes Target BGs/Protocols Difference between insulins and how they are given How/when to test consistently Treatment and prevention of hypoglycemia Documentation pathways Terms and definitions

Definitions Hyperglycemia is a blood sugar over 110 in a fasting patient and over 125 in a patient who has eaten. Hypoglycemia40-70 mg/Dl Point of care testing –Immediate results that alter management Diabetes mellitus –Types I and II, gestational Hyperglycemia –Steroids –Stress –Other meds

Conditions that Predispose to Hypoglycemia Advanced age Decreased oral intake Chronic renal failure Liver disease Use of Beta blockers Mistiming of meals in relationship to insulin dosing Infrequent or missed monitoring Lack of coordination with transportation and floor Knowledge deficits by providers Unreadable, unusual or convoluted orders Difficult to follow protocols Physician insisting on different protocol

What is the evidence? Risk of microvascular complications –Renal and retinal disease –Diabetes Control and Complications Trial Risk of macrovascular complications –CAD and stroke –Capes SE. Stroke 2001; 32:2427 –DIGAMI and Malmberg K. Circulation : Risk of mortality Risk of infections Cost of care ACE and AACE recommendations

Unanswered Questions What is optimal control? How long does the patient need to be in good control? Can we take tight control too far? What is the role of lipids in glucose control? Do we need to aggressively treat other medical conditions at the same time?

The Role of Blood Sugar in Infections Poor wound healing in general/many already colonized Deoxyglucose inhibits glycolytic metabolism which generates energy for superoxide production No absolute Km identified but glucose level proportional to neutrophil activity Granulocyte functionsimprove when glucose control is goodi.e. <200mg/dL –Adherence –Delays chemotaxis –Impairs phagocytosis –Decreased bacteriocidal activity

Other DM Complications in Surgery Cellular immunity –Decreased complement fixation Collagenincreased collagenase activity Role of microvascular damage 34% of insulin dependent diabetics are colonized with s. aureus Cardiac cellular function

Vanderbilt Study Latham R. et.al. Infact Control Hosp Epidemiol. 2001; 22: Prospective, 1044 CABG and valve ops 6% had undiagnosed diabetes SSI pts.62% of known diabetics had hyperglycemia/37% of non-DM patients Dx of DM associated with 2.7X risk for SSI Rate of SSIs correlated with degree of hyperglycemia Hyperglycemia during periop is independent risk factor

Vanderbilt, cont Similar to other studies, 6% were undiagnosed diabetics 19% in this study had abnormal HgbA1c and another 11% had glucose >200 But Hgb A1c did not correlate with SSIs Still, suggest that screening with HgbA1c for diagnosis of DM is cost effective if therapy is initiated

Perioperative Glucose Control 1,000 cardiothoracic surgery patients Diabetics and non-diabetics with hyperglycemia Patients with a blood sugar > 300 mg/dL during or within 48 hours of surgery had more than 3X the likelihood of a wound infection! Latham R, et al. Infect Control Hosp Epidemiol

What factor makes the difference? Patients may be undiagnosed (4.2%--or higher!) Most infections when glucose level is >200 mg/dL Risk same if glucose high anytime in first 48 hours Hyperglycemia doubles risk22.7X –20mg/Dl increase = 30% increase risk of death May directly affect cardiac cellular function Can be stress or medication induced –Capes SE. Lancet and Clement S. Diabetes Care :

Aint No Mountain High Enough… Enormous percentage of our patients are diabetic Another percentage are undiagnosed or hyperglycemic from other causes Adding nutrition and crisis management Source of blood Timing of testing Tests used

Aint no Valley Low Enough… Hypoglycemia is a blood glucose of Institution dependent Cause seizures, brain death if too low Anesthesia and sedation block usual symptoms Blood source Timing of testing Tests used

Is There a River Wide Enough? Who is the crew and who is the coxswain? Untraditional looking crew –Nutritionist, Pharmacist, QI/PI, managers –Lab, nurses, doctors, educators Constant educational needs Policies Which protocol? Point of care testing and decision making Patients go through multiple units while in the hospitaltransitions are trouble points Costs/equipment

Protocol, protocol, who has a protocol? Portland, van den Berghe, Yale, home-grown? Elements to look for –While NPO, when feeding, when crisis –Timing of doses/testing –Subcu vs IVcontinuous (CII) vs. bolus –Different protocol for night shift, for sicker patients, for iconoclastic docs? Start higher to avoid going lowerhow low is too low? How many get hypoglycemic on each protocol? KISS –or not? Education, re-education and more education Requires an IV for most of the protocols

UVA Protocol ICU generated 95 is ICU target, <175 is SIP target, is general floor target No subcu Tests q 1h till stable X 2, then q 2h Hypoglycemia at 80 mg/Dl--!!! This is very unusual Capillary unless needs checking, then venous not sure why we do not use arterial in ICU

UVA SIP Glucose Compliance

Portland Furnary. J Thorac CardiovascSurg, 2003; 125: Endocr Pract 2004; 10: Tests q.5-2 hrs Continuous IV only Avg. 3 day Blood glucose 13,649 patients since 1987prospective interventional 1.5% hypoglycemia rate (60 mg/Dl)

van den Berghe NEJM : SICU patients. Randomized, prospective, controlled. IV insulin to maintain between 80 and 110 mg/Dl Relatively short Measures q 2h until goal, then q 4h Hypoglycemia at 60 No additional protocols for adding nutrition, crises, weaning

Yale Goldberg PA, et al. Diabetes Care. 2004; 27: Current BG leads you to table. Hourly rate of change is guide. Nomogram. Complicated. Target is mg/Dl. Very little hypoglycemia Mean time to target is 4.6 hrs. Median is 9 hrs. Protocol rated easy, no additions for nutrition, weaning, crises.

Other protocols MarkovitzEndocr Pract. 2002; 8:10-16 –Has default algorithm –Testing frequency lowers as stabilizes –Hourly rate=hourly maintenance rate +(blood glucose- 150)/ISF –Cut off is 100 UNCnot published yet –Target of Has no hypoglycemia cut-off. Florida Hospitalnot published, looks like blend of Markovitz format and Portland amounts Glucommander

Free Form Protocols-Basic Concepts Usual start dose is 0.15 u/kg Continuous IV weaned to bolus weaned to usual Think Basal/Nutritional/Correction (Crisis) as three distinct levels with different needs Basal needs long acting agent like glargine Nutritional needs medium acting at 1 unit/10 gms of CHO Crisis/correctional needs short acting like Lispro or Aspartine

More Basics to Keep in Mind Use regular insulin or NPH in drips Regular insulin at doses of unit/ml Infuse at 0.1 unit dose increments Use IV fluids with glucoseusually D5 Monitor potassium Have D50 available and oral CHO also.

But is CII cheaper than SQ? Direct and indirect costs for 3 days of q 4h SQ=$32/pt Costs of 3 days of Cont IV infusion with q 1-2 h test =$170/pt ($138 difference) Cost of DSWI =$2613/pt + $2081 for 1.8 additional days $ =$4556/pt or $4,556,000 per 1000 CABGs US Hospital savings = 103K CABGs =$469 million/yr

Point of Care Testing Essential Timing is crucial Which blood source? Urine? Same over time? Sensitivity vs. specificity What interferes with the test you use? No way to get trends at this time What would you want in a testor that you do not have now…? Who needs to be involved? What skills do they need or bring to share?

More on POC Testing Bedside monitoring vs. central lab Does the person doing the test matter? Self-monitoring? Cost, accuracy, accountability Will we live long enough to see a non- invasive bedside monitor? Wireless? Ketones, albumin, HbA1c, glycated serum proteins-better than blood glucose?

The Pieces You Need Know the literature and other rationales Have a credible champion The right protocol Forms, policies and order sets The right team Enough equipment Strong Quality Improvement department

What to Do with the Pieces Start with one unit Keep all data in one place Solid communication system Accurate test administered by trained professionals Timely changes in treatment Start high, move lower Never stop educating Have a safety plan Consider special circumstances

Data that may help you… Knowing what percentage of patients are diabeticand guesstimating percent of unrecognized hyperglycemic patients Literature Knowing what surgical infection rate is Estimating cost to your institution in terms of: –Mortality –LOS –Financial Costs

Thanks… Questions, comments, suggestions?